ASMB
Price
$24.71
Change
+$0.72 (+3.00%)
Updated
Aug 13, 04:59 PM (EDT)
Capitalization
180.76M
COGT
Price
$11.98
Change
+$0.43 (+3.72%)
Updated
Aug 13, 04:59 PM (EDT)
Capitalization
1.53B
96 days until earnings call
Interact to see
Advertisement

ASMB vs COGT

Header iconASMB vs COGT Comparison
Open Charts ASMB vs COGTBanner chart's image
Assembly Biosciences
Price$24.71
Change+$0.72 (+3.00%)
Volume$20.84K
Capitalization180.76M
Cogent Biosciences
Price$11.98
Change+$0.43 (+3.72%)
Volume$62.46K
Capitalization1.53B
ASMB vs COGT Comparison Chart in %
Loading...
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASMB vs. COGT commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a StrongBuy and COGT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 14, 2025
Stock price -- (ASMB: $23.99 vs. COGT: $11.55)
Brand notoriety: ASMB and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASMB: 229% vs. COGT: 34%
Market capitalization -- ASMB: $180.76M vs. COGT: $1.53B
ASMB [@Biotechnology] is valued at $180.76M. COGT’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASMB’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • ASMB’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, ASMB is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASMB’s TA Score shows that 4 TA indicator(s) are bullish while COGT’s TA Score has 5 bullish TA indicator(s).

  • ASMB’s TA Score: 4 bullish, 4 bearish.
  • COGT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than ASMB.

Price Growth

ASMB (@Biotechnology) experienced а +27.20% price change this week, while COGT (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.47%. For the same industry, the average monthly price growth was +20.22%, and the average quarterly price growth was +20.09%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+11.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.53B) has a higher market cap than ASMB($181M). ASMB YTD gains are higher at: 52.028 vs. COGT (48.077). ASMB has higher annual earnings (EBITDA): -44.5M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. ASMB (91M). ASMB has less debt than COGT: ASMB (3.02M) vs COGT (17.1M). ASMB has higher revenues than COGT: ASMB (32.2M) vs COGT (0).
ASMBCOGTASMB / COGT
Capitalization181M1.53B12%
EBITDA-44.5M-284.04M16%
Gain YTD52.02848.077108%
P/E RatioN/AN/A-
Revenue32.2M0-
Total Cash91M246M37%
Total Debt3.02M17.1M18%
FUNDAMENTALS RATINGS
ASMB vs COGT: Fundamental Ratings
ASMB
COGT
OUTLOOK RATING
1..100
2375
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3637
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASMB's Valuation (63) in the Pharmaceuticals Other industry is in the same range as COGT (87) in the Miscellaneous industry. This means that ASMB’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (95) in the Miscellaneous industry is in the same range as ASMB (100) in the Pharmaceuticals Other industry. This means that COGT’s stock grew similarly to ASMB’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as ASMB (99) in the Pharmaceuticals Other industry. This means that COGT’s stock grew similarly to ASMB’s over the last 12 months.

ASMB's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as COGT (37) in the Miscellaneous industry. This means that ASMB’s stock grew similarly to COGT’s over the last 12 months.

ASMB's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as COGT (100) in the Miscellaneous industry. This means that ASMB’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASMBCOGT
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 27 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGMX20.730.17
+0.83%
NYLI PineStone Global Equity Class R6
ROGSX54.28N/A
N/A
Red Oak Technology Select
HILAX23.20N/A
N/A
Hartford International Value A
BIRDX8.28N/A
N/A
iShares Developed Real Estate Idx Instl
CRLSX10.95N/A
N/A
Catholic Rspnsbl Invstmnts Intl Eq Ins

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
+1.65%
SPRC - ASMB
45%
Loosely correlated
-3.75%
NKTX - ASMB
42%
Loosely correlated
-2.49%
ZYME - ASMB
35%
Loosely correlated
+4.66%
VKTX - ASMB
35%
Loosely correlated
+4.37%
COGT - ASMB
34%
Loosely correlated
+5.67%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+5.67%
SPHDF - COGT
63%
Loosely correlated
N/A
ATXS - COGT
50%
Loosely correlated
-0.45%
CGON - COGT
49%
Loosely correlated
+4.20%
XNCR - COGT
49%
Loosely correlated
+10.71%
IDYA - COGT
48%
Loosely correlated
+3.28%
More